Back to All Services
Our Services
Health Economics Research
At Medicys we partner with, and are preferred suppliers to, many leading health economics firms who focus on measuring and valuing the outcomes of healthcare interventions and who seek to understand how to navigate regulatory frameworks and Health Technology Assessment processes.
Specifically, our pricing and market access specialists recruit, interview and report on our network of local, regional and national payers (and ex payers) and Payer Advising Key Opinion Leaders (PA-KOLs) on topics such as:
- Economic Evaluation
- Cost of illness
- Cost comparison, effectiveness, utility and benefit
- Thresholds and opportunity costs
- Value driven healthcare systems
- Health Policy and Regulatory frameworks
- Approval and labelling
- Pricing Policy and pricing Schemes
- Reimbursement and access
- Insurance systems and national healthcare
- Public spending and national health expenditures
- Procurement systems
- Risk sharing approaches
- Health Technology Assessment
- Systems and structure
- Value framework and dossier format
- Decisions and deliberative processes
Our projects in this discipline usually take the form of Web Assisted Telephone Depth Interviews (WATDIs), online groups or advisory boards (digital or in person).
Related Work
See all Work
health economics research
To explore the perception of value and available evidence for preeclampsia biomarker test for pregnant women hospitalized for hypertensive disorders of pregnancy, understand additional evidence needs for reimbursement, to develop an actionable US access strategy for pre-eclampsia biomarker test
health economics research
Methicillin-resistant Staphylococcus aureus
+2
Infectious disease physicians, heads of department
To assess some TPPs and to determine keys to success, utilization and payer reactions and pricing
health economics research
To understand how payers find, evaluate and approve information for funding devices, and in their experience, what is most useful, or most frustrating. To understand how interactions with device manufacturers and diabetes medical device companies has changed since the pandemic, and about how things may developing over the next few years.
health economics research
Assess payer perception and consideration for making decisions around access, formulary inclusion, and pricing for an existing injectable biologic
Request a quote
